数据链接:
官方服务:
资源简介:
我司通过合法途径获得胃癌细胞,对实验室观察收集到的相关原始数据进行了专业的预处理、计算转换和验证调整,最终形成了具有独立价值的胃癌PDC/PDO/PDX多模态衍生数据集。
应用场景:
提供机构:
合肥中科普瑞昇生物医药科技有限公司创建时间:
2025-12-22
相关数据集
恶性肿瘤PDC/PDO/PDX模型构建及检测数据集
我司通过合法途径获得恶性肿瘤细胞,对实验室观察收集到的相关原始数据进行了专业的预处理、计算转换和验证调整,最终形成了具有独立价值的恶性肿瘤PDX多模态衍生数据集。
安徽省数据产权登记平台140
Discovery of Novel Bifunctional Agents as Potent TRK Inhibitors and Degraders against xDFG Mutation Resistance
Despite the clinical success of tropomyosin receptor kinases (TRKs) inhibitors in NTRK fusion–positive cancers, prolonged administration has resulted in acquired resistance, particularly xDFG mutation
NIAID Data Ecosystem50
Xenografting of advanced stage breast cancer preserves the genomic and clonal architecture and captures luminal tumors harboring mutations and gene rearrangements in ESR1
End-stage breast cancers are clonally heterogeneous and harbor many poorly-understood treatment resistance mechanisms. We therefore established multiple Patient-Derived-Xenograft (PDX) models to stud
NIAID Data Ecosystem30
Oncology Based In-vivo CRO Market
Global Oncology Based In-vivo CRO Market Report 2024 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market
IMR REPORTS50
North America Patient Derived Xenograft & PDX Models Market
North America Patient Derived Xenograft & PDX Models comes with extensive industry analysis of development components, patterns, flows, and sizes. The report calculates present and past market values
IMR REPORTS40



